Indivior PLC (GBP)
INDV
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range0.40 | 0.43
52-Wk Range0.21 | 1.31
Last Close0.40
Mkt Cap (m)293.04
Dividend yield-
ISINGB00BRS65X63
Volume2,234,553
Exchange VenueLON

Company Profile

Indivior PLC is a US-based specialty and generic drug manufacturin eneric drug manufacturg company. The firm develops, manufactures, and sells prescription drugs that are mainly based on buprenorphine for treatment of opioid dependence.

Key Information
Price/Earning1.86
Price/Book1.57
Price/Sales0.46
P/CF2.04
Rev Growth (3 year avg)-0.30
EPS Growth (3 year avg)0.06
Operating Margin % 31.44
Net Margin %27.36
Return on Equity-
Debt/Equity3.65

Legal Documents

Prospectus
en 17/11/2014
Annual Report
en 31/12/2018

Financials

Income Statement
GBP201320142015201620172018
Revenue (m)1,2161,1151,0141,0581,0931,005
Operating Income (m)695562346149193316
Net Income (m)4584032283558275
Basic EPS0.620.560.320.050.080.38
Avg. Diluted Shares Outstanding (m)737724733743748751
Balance Sheet
GBP201320142015201620172018
Current Assets (m)2285657219901,2251,329
Non Current Assets (m)198182216219219218
Total Assets (m)4267479371,2091,4441,547
Current Liabilities (m)4514626031,030854818
Total Liabilities (m)------
Total Equity (m)-66-475-279-295-20366
Cash Flows
GBP201320142015201620172018
Operating Cash Flows (m)791440320407295303
Capital Expenditure (m)-3-26-31-35-43-41
Figures are quoted in GBP unless stated otherwise
0.00 (0.00%)
£
0.40
Last Price